Global Oral Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 09-May-2019
No. of pages: 129
Inquire Before Buying

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

The global Oral Vaccine market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Oral Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Oral Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Oral Vaccine in these regions.

This research report categorizes the global Oral Vaccine market by top players/brands, region, type and end user. This report also studies the global Oral Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Merck

- GSK

- Sanofi

- Lanzhou Institute

- Serum Institute

- Valneva

- Shanghai United Cell

- Bibcol

- PaxVax

- Vabiotech

- Tiantan Biological

- EuBiologics

- Panacea Biotec Ltd

- Bio-Med

- Halfkin Bio-Pharmaceuticals

Market size by Product

- Rotavirus Vaccine

- Cholera Vaccine

- Oral Polio Vaccine

- Others

Market size by End User

- Public

- Private

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Oral Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Oral Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Oral Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Oral Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Oral Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Oral Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Oral Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Oral Vaccine Market Size Growth Rate by Product
1.4.2 Rotavirus Vaccine
1.4.3 Cholera Vaccine
1.4.4 Oral Polio Vaccine
1.4.5 Others
1.5 Market by End User
1.5.1 Global Oral Vaccine Market Size Growth Rate by End User
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Oral Vaccine Market Size
2.1.1 Global Oral Vaccine Revenue 2014-2025
2.1.2 Global Oral Vaccine Sales 2014-2025
2.2 Oral Vaccine Growth Rate by Regions
2.2.1 Global Oral Vaccine Sales by Regions
2.2.2 Global Oral Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Oral Vaccine Sales by Manufacturers
3.1.1 Oral Vaccine Sales by Manufacturers
3.1.2 Oral Vaccine Sales Market Share by Manufacturers
3.1.3 Global Oral Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Oral Vaccine Revenue by Manufacturers
3.2.1 Oral Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Oral Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Oral Vaccine Price by Manufacturers
3.4 Oral Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Oral Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oral Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Oral Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Oral Vaccine Sales by Product
4.2 Global Oral Vaccine Revenue by Product
4.3 Oral Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Oral Vaccine Breakdown Data by End User
6 North America
6.1 North America Oral Vaccine by Countries
6.1.1 North America Oral Vaccine Sales by Countries
6.1.2 North America Oral Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Oral Vaccine by Product
6.3 North America Oral Vaccine by End User
7 Europe
7.1 Europe Oral Vaccine by Countries
7.1.1 Europe Oral Vaccine Sales by Countries
7.1.2 Europe Oral Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Oral Vaccine by Product
7.3 Europe Oral Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Oral Vaccine by Countries
8.1.1 Asia Pacific Oral Vaccine Sales by Countries
8.1.2 Asia Pacific Oral Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Oral Vaccine by Product
8.3 Asia Pacific Oral Vaccine by End User
9 Central & South America
9.1 Central & South America Oral Vaccine by Countries
9.1.1 Central & South America Oral Vaccine Sales by Countries
9.1.2 Central & South America Oral Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Oral Vaccine by Product
9.3 Central & South America Oral Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Oral Vaccine by Countries
10.1.1 Middle East and Africa Oral Vaccine Sales by Countries
10.1.2 Middle East and Africa Oral Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Oral Vaccine by Product
10.3 Middle East and Africa Oral Vaccine by End User
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Business Overview
11.1.3 Merck Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Merck Oral Vaccine Products Offered
11.1.5 Merck Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 Company Business Overview
11.2.3 GSK Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GSK Oral Vaccine Products Offered
11.2.5 GSK Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Oral Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Company Details
11.4.2 Company Business Overview
11.4.3 Lanzhou Institute Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Lanzhou Institute Oral Vaccine Products Offered
11.4.5 Lanzhou Institute Recent Development
11.5 Serum Institute
11.5.1 Serum Institute Company Details
11.5.2 Company Business Overview
11.5.3 Serum Institute Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Serum Institute Oral Vaccine Products Offered
11.5.5 Serum Institute Recent Development
11.6 Valneva
11.6.1 Valneva Company Details
11.6.2 Company Business Overview
11.6.3 Valneva Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Valneva Oral Vaccine Products Offered
11.6.5 Valneva Recent Development
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Company Details
11.7.2 Company Business Overview
11.7.3 Shanghai United Cell Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Shanghai United Cell Oral Vaccine Products Offered
11.7.5 Shanghai United Cell Recent Development
11.8 Bibcol
11.8.1 Bibcol Company Details
11.8.2 Company Business Overview
11.8.3 Bibcol Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Bibcol Oral Vaccine Products Offered
11.8.5 Bibcol Recent Development
11.9 PaxVax
11.9.1 PaxVax Company Details
11.9.2 Company Business Overview
11.9.3 PaxVax Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 PaxVax Oral Vaccine Products Offered
11.9.5 PaxVax Recent Development
11.10 Vabiotech
11.10.1 Vabiotech Company Details
11.10.2 Company Business Overview
11.10.3 Vabiotech Oral Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Vabiotech Oral Vaccine Products Offered
11.10.5 Vabiotech Recent Development
11.11 Tiantan Biological
11.12 EuBiologics
11.13 Panacea Biotec Ltd
11.14 Bio-Med
11.15 Halfkin Bio-Pharmaceuticals
12 Future Forecast
12.1 Oral Vaccine Market Forecast by Regions
12.1.1 Global Oral Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Oral Vaccine Revenue Forecast by Regions 2019-2025
12.2 Oral Vaccine Market Forecast by Product
12.2.1 Global Oral Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Oral Vaccine Revenue Forecast by Product 2019-2025
12.3 Oral Vaccine Market Forecast by End User
12.4 North America Oral Vaccine Forecast
12.5 Europe Oral Vaccine Forecast
12.6 Asia Pacific Oral Vaccine Forecast
12.7 Central & South America Oral Vaccine Forecast
12.8 Middle East and Africa Oral Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oral Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Oral Vaccine Product Picture
Table Oral Vaccine Market Segments
Table Key Manufacturers Oral Vaccine Covered
Table Global Oral Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Oral Vaccine Sales Market Share by Product 2014-2025
Figure Rotavirus Vaccine Product Picture
Table Major Manufacturers of Rotavirus Vaccine
Figure Cholera Vaccine Product Picture
Table Major Manufacturers of Cholera Vaccine
Figure Oral Polio Vaccine Product Picture
Table Major Manufacturers of Oral Polio Vaccine
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Oral Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Public
Figure Private
Figure Oral Vaccine Report Years Considered
Figure Global Oral Vaccine Market Size 2014-2025 (Million US$)
Figure Global Oral Vaccine Sales 2014-2025 (K Units)
Table Global Oral Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Oral Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Oral Vaccine Sales Market Share by Regions 2014-2019
Figure Global Oral Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Oral Vaccine Sales Market Share by Regions
Table Global Oral Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Oral Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Oral Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Oral Vaccine Revenue Market Share by Regions
Table Global Oral Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Oral Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Oral Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Oral Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Oral Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Oral Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Oral Vaccine Price (2014-2019) (USD/Unit)
Table Oral Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Oral Vaccine Product Type
Table Date of International Manufacturers Enter into Oral Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Oral Vaccine Sales by Product (2014-2019) (K Units)
Table Global Oral Vaccine Sales Share by Product (2014-2019)
Figure Global Oral Vaccine Sales Market Share by Product (2014-2019)
Figure Global Oral Vaccine Sales Market Share by Product in 2018
Table Global Oral Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Oral Vaccine Revenue Share by Product (2014-2019)
Figure Global Oral Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Oral Vaccine Revenue Market Share by Product in 2018
Table Oral Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Oral Vaccine Sales by End User (2014-2019) (K Units)
Table Global Oral Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Oral Vaccine Market Share by End User (2014-2019)
Figure Global Sales Oral Vaccine Market Share by End User in 2018
Figure North America Oral Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Oral Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Oral Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Oral Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Oral Vaccine Sales Market Share by Countries
Table North America Oral Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Oral Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Oral Vaccine Revenue Market Share by Countries
Figure United States Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Oral Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Oral Vaccine Sales by Product (2014-2019) (K Units)
Table North America Oral Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Oral Vaccine Market Share by Product
Table North America Oral Vaccine Sales by End User (2014-2019) (K Units)
Table North America Oral Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Oral Vaccine Market Share by End User
Figure Europe Oral Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Oral Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Oral Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Oral Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Oral Vaccine Sales Market Share by Countries
Table Europe Oral Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Oral Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Oral Vaccine Revenue Market Share by Countries
Figure Germany Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Oral Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Oral Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Oral Vaccine Market Share by Product
Table Europe Oral Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Oral Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Oral Vaccine Market Share by End User
Figure Asia Pacific Oral Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Oral Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Oral Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Oral Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Oral Vaccine Sales Market Share by Countries
Table Asia Pacific Oral Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Oral Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Oral Vaccine Revenue Market Share by Countries
Figure China Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Oral Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Oral Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Oral Vaccine Market Share by Product
Table Asia Pacific Oral Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Oral Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Oral Vaccine Market Share by End User
Figure Central & South America Oral Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Oral Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Oral Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Oral Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Oral Vaccine Sales Market Share by Countries
Table Central & South America Oral Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Oral Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Oral Vaccine Revenue Market Share by Countries
Figure Brazil Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Oral Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Oral Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Oral Vaccine Market Share by Product
Table Central & South America Oral Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Oral Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Oral Vaccine Market Share by End User
Figure Middle East and Africa Oral Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Oral Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Oral Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Oral Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Oral Vaccine Sales Market Share by Countries
Table Middle East and Africa Oral Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Oral Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Oral Vaccine Revenue Market Share by Countries
Figure GCC Countries Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Oral Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Oral Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Oral Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Oral Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Oral Vaccine Market Share by Product
Table Middle East and Africa Oral Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Oral Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Oral Vaccine Market Share by End User
Table Merck Company Details
Table Merck Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table GSK Company Details
Table GSK Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GSK Recent Development
Table Sanofi Company Details
Table Sanofi Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Lanzhou Institute Company Details
Table Lanzhou Institute Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Lanzhou Institute Recent Development
Table Serum Institute Company Details
Table Serum Institute Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Serum Institute Recent Development
Table Valneva Company Details
Table Valneva Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Valneva Recent Development
Table Shanghai United Cell Company Details
Table Shanghai United Cell Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Shanghai United Cell Recent Development
Table Bibcol Company Details
Table Bibcol Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bibcol Recent Development
Table PaxVax Company Details
Table PaxVax Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table PaxVax Recent Development
Table Vabiotech Company Details
Table Vabiotech Oral Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Vabiotech Recent Development
Table Tiantan Biological Company Details
Table EuBiologics Company Details
Table Panacea Biotec Ltd Company Details
Table Bio-Med Company Details
Table Halfkin Bio-Pharmaceuticals Company Details
Table Global Oral Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Oral Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Oral Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Oral Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Oral Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Oral Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Oral Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Oral Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Oral Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Oral Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Oral Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Oral Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Oral Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Oral Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Oral Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Oral Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Oral Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Oral Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Oral Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Oral Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Oral Vaccine Value Chain
Table Oral Vaccine Customers List
Table Oral Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs